{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:27:56Z","timestamp":1783056476596,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["LSHG-CT-2006-037683"],"award-info":[{"award-number":["LSHG-CT-2006-037683"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical &amp; Translational Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jcte.2019.100185","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T21:15:10Z","timestamp":1550610910000},"page":"100185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Gestational diabetes mellitus and macrosomia predispose to diabetes in the Lebanese population"],"prefix":"10.1016","volume":"16","author":[{"given":"Michella","family":"Ghassibe-Sabbagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal Abi","family":"Farraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique K.","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre A.","family":"Zalloua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcte.2019.100185_b0005","first-page":"597","article-title":"What is type 2 diabetes?","volume":"38","author":"Smushkin","year":"2010","journal-title":"Medicine (Abingdon)"},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/diaclin.21.1.14","article-title":"Clarifying the role of insulin in type 2 diabetes management","volume":"21","author":"White","year":"2003","journal-title":"Clin Diabet"},{"issue":"9","key":"10.1016\/j.jcte.2019.100185_b0015","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4158\/EP171876.OR","article-title":"Prevalence of diabetes in greater Beirut area: worsening over time","volume":"23","author":"Nasrallah","year":"2017","journal-title":"Endocr Pract."},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12889-018-5416-7","article-title":"Knowledge and practice of patients with diabetes mellitus in Lebanon: a cross-sectional study","volume":"18","author":"Karaoui","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jcte.2019.100185_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.23937\/2377-3634\/1410050","article-title":"A Comprehensive analysis of the financial burden of diabetes mellitus at Rafik Hariri University Hospital: the economic implications from the public sector perspective in Lebanon","volume":"2","author":"Echtay","year":"2015","journal-title":"Int J Diabetes Clin Res"},{"issue":"Suppl 1","key":"10.1016\/j.jcte.2019.100185_b0030","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2019.100185_b0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphys.2016.00124","article-title":"Poly cystic ovarian syndrome: an updated overview","volume":"7","author":"El Hayek","year":"2016","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.jcte.2019.100185_b0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jcte.2019.100185_b0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12916-015-0299-2","article-title":"Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro","volume":"13","author":"Legro","year":"2015","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam EA-SPCWG","year":"2004","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jcte.2019.100185_b0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0889-8529(05)70330-3","article-title":"Hypertension in diabetes mellitus","volume":"25","author":"Arauz-Pacheco","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2019.100185_b0065","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2337\/dc07-s201","article-title":"What is gestational diabetes?","volume":"30","author":"Buchanan","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2019.100185_b0070","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.2337\/dc07-s202","article-title":"Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes","volume":"30","author":"Barbour","year":"2007","journal-title":"Diabetes Care"},{"issue":"9677","key":"10.1016\/j.jcte.2019.100185_b0075","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jcte.2019.100185_b0080","first-page":"S25","article-title":"Future risk of diabetes in mother and child after gestational diabetes mellitus","volume":"104","author":"Damm","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"5 Suppl 2","key":"10.1016\/j.jcte.2019.100185_b0085","doi-asserted-by":"crossref","first-page":"1674S","DOI":"10.1093\/jn\/133.5.1674S","article-title":"Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus","volume":"133","author":"Catalano","year":"2003","journal-title":"J Nutr."},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0090","first-page":"158","article-title":"Macrosomia\u2013maternal characteristics and infant complications","volume":"66","author":"Spellacy","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jcte.2019.100185_b0095","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4103\/2141-9248.122098","article-title":"Fetal macrosomia: risk factors, maternal, and perinatal outcome","volume":"3","author":"Mohammadbeigi","year":"2013","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.jcte.2019.100185_b0100","unstructured":"Control CfD, Prevention. Women at high risk for diabetes: physical activity, healthy eating and weight loss; 2011. Retrieved from htttp:\/\/www.cdc.gov\/diabetes\/pubs\/pdf\/womenHighRiskDiabetes.pdf."},{"key":"10.1016\/j.jcte.2019.100185_b0105","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1038\/srep07351","article-title":"T2DM GWAS in the Lebanese population confirms the role of TCF7L2 and CDKAL1 in disease susceptibility","volume":"4","author":"Ghassibe-Sabbagh","year":"2014","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0110","article-title":"Evidence for insulin resistance in polycystic ovary syndrome (PCO)","volume":"31","author":"Lobo","year":"1983","journal-title":"Clin Res"},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.jcte.2019.100185_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mce.2012.10.029","article-title":"Longterm management of Polycystic Ovarian Syndrome (PCOS)","volume":"373","author":"Bates","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jcte.2019.100185_b0130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jcte.2019.100185_b0135","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"issue":"27","key":"10.1016\/j.jcte.2019.100185_b0140","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians","volume":"329","author":"Lillioja","year":"1993","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcte.2019.100185_b0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4158\/EP11375.OR","article-title":"Pancreatic beta-cell dysfunction in polycystic ovary syndrome: the role of metformin","volume":"18","author":"Messer","year":"2012","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.jcte.2019.100185_b0150","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2019.100185_b0155","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.2337\/diabetes.54.suppl_2.S108","article-title":"Mechanisms of beta-cell death in type 2 diabetes","volume":"54","author":"Donath","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2019.100185_b0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2013.11.011","article-title":"Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors","volume":"173","author":"Shi","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.jcte.2019.100185_b0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0175","first-page":"56","article-title":"A Review on the assessment of the efficacy of common treatments in polycystic ovarian syndrome on prevention of diabetes mellitus","volume":"11","author":"Dashti","year":"2017","journal-title":"J Family Reprod Health"},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1464-5491.2003.00985.x","article-title":"Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes","volume":"21","author":"Ben-Haroush","year":"2004","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.jcte.2019.100185_b0185","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","article-title":"Gestational diabetes and the incidence of type 2 diabetes: a systematic review","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcte.2019.100185_b0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/diacare.29.03.06.dc05-1118","article-title":"Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies","volume":"29","author":"Jarvela","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jcte.2019.100185_b0195","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diab.44.5.506","article-title":"Defects in insulin secretion and action in women with a history of gestational diabetes","volume":"44","author":"Ryan","year":"1995","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.jcte.2019.100185_b0200","first-page":"B43","article-title":"Risk and prevention of type 2 diabetes in women with gestational diabetes","volume":"21","author":"Dornhorst","year":"1998","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.jcte.2019.100185_b0205","first-page":"S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","author":"Expert Committee on the D","year":"2003","journal-title":"Diabetes Care."},{"issue":"12","key":"10.1016\/j.jcte.2019.100185_b0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/M15-0807","article-title":"Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a prospective cohort study","volume":"163","author":"Gunderson","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/14767058.2016.1163679","article-title":"Pre-pregnancy body mass index (BMI) and macrosomia in a Canadian birth cohort","volume":"30","author":"Vinturache","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jcte.2019.100185_b0220","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.5888\/pcd10.120336","article-title":"Gestational age, infant birth weight, and subsequent risk of type 2 diabetes in mothers: Nurses' Health Study II","volume":"10","author":"James-Todd","year":"2013","journal-title":"Prev Chronic Dis."},{"issue":"2","key":"10.1016\/j.jcte.2019.100185_b0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000371628","article-title":"Gestational diabetes mellitus and macrosomia: a literature review","volume":"66","author":"Kc","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jcte.2019.100185_b0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.11604\/pamj.2017.26.62.11440","article-title":"Frequency of fetal macrosomia and the associated risk factors in pregnancies without gestational diabetes mellitus","volume":"26","author":"Usta","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"8","key":"10.1016\/j.jcte.2019.100185_b0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1358\/dot.2013.49.8.2002839","article-title":"Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance","volume":"49","author":"Smith-Marsh","year":"2013","journal-title":"Drugs Today (Barc)"},{"issue":"19","key":"10.1016\/j.jcte.2019.100185_b0240","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Group HSCR","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcte.2019.100185_b0245","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.diabres.2012.09.002","article-title":"Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment","volume":"98","author":"Falavigna","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.jcte.2019.100185_b0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejogrb.2007.03.022","article-title":"Pregnancy outcome in obese and morbidly obese gestational diabetic women","volume":"137","author":"Yogev","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Journal of Clinical &amp; Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623718301376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623718301376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:56:43Z","timestamp":1762005403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623718301376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"alternative-id":["S2214623718301376"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2019.100185","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational diabetes mellitus and macrosomia predispose to diabetes in the Lebanese population","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2019.100185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100185"}}